期刊文献+

高效液相色谱法测定盐酸氨溴索注射液中2种杂质的含量 被引量:2

Content of 2 impurities in ambroxol hydrochloride injection by HPLC
下载PDF
导出
摘要 目的采用高效液相色谱法测定盐酸氨溴索注射液中2种有关物质的含量。方法采用辛烷基硅烷键合硅胶Kromasil 100-5C8柱(250 mm×4.6 mm,5μm),以磷酸二氢铵缓冲液(取磷酸氢二铵2 g,溶于800m L水中,用磷酸调p H值至4.0,再加水稀释成1 000 m L)-甲醇(45:55)为流动相,流速为1.0 mL·min^-1,检测波长分别为238、250 nm,柱温:30℃。结果杂质B反-4-(6,8-二溴-1,2,3,4-四氢喹唑啉-3-基)环己醇和杂质E 2-氨基-3,5-二溴苯甲醛的检出限分别为9.39 ng、3.70 ng,定量限分别为18.78 ng、11.10ng;线性范围分别为0.376-18.8μg·mL^-1(r=0.999 9)、0.386-7.72μg·mL^-1(r=0.999 8),平均加样回收率均在99.8%-100.1%,RSD均〈0.5%。结论该方法测定盐酸氨溴索注射液中的有关物质方法简便、准确、专属性强,可用于盐酸氨溴索注射液中有关物质的质量控制。 Objective To establish an HPLC method to determine related substances in ambroxol hydrochloride injection. Methods Kromasil 100-5C8 column(250 mm×4.6 mm, 5 μm) was used. The mobile phase was ammonium dibasic phosphate buffer(p H = 4.0)-methanol(45 :55) at 1.0 m L·min^- 1. The detection wavelength was 238 nm and 250 nm, the column temperature was 30 ℃. Results The minimum detection limit of impurity B trans-4-{[(2-amino-3, 5-dibromophenyl) methyl] amino}-cyclohexanol and impurity E 2-amino-3, 5-two bromo benzaldehyde was 9.39 ng and 3.70 ng, respectively. The limits of quantification were 18.78 ng and 11.10 ng. The calibration curve of impurity B and impurity E had good linearity at 0.376- 18.8 μg·mL^- 1(r = 0.999 9) and 0.386- 7.72 μg·mL^- 1(r= 0.999 8). The average recoveries of impurity B and impurity E were at 99.8%- 100.1%, with RSDs were less than 0.5%. Conclusion This method is easy to operate, reliable and highly sensitivite, which can be used to control the related substances in ambroxol hydrochloride injection.
机构地区 中南大学药学院
出处 《中南药学》 CAS 2014年第11期1136-1138,共3页 Central South Pharmacy
关键词 盐酸氨溴索注射液 杂质B 杂质E 高效液相色谱法 ambroxol hydrochloride injection impurity B impurity E HPLC
  • 相关文献

参考文献4

二级参考文献25

  • 1张玲玲,邓意辉,周欣羽,吴红兵,徐速.盐酸氨溴索三层泡腾片的制备及稳定性的因素考察[J].中国新药杂志,2006,15(9):705-708. 被引量:3
  • 2沈金芳,崔岚.3种盐酸氨溴索注射剂的稳定性比较[J].中国新药杂志,2006,15(22):1955-1957. 被引量:4
  • 3Fu YR, Yang SC, Jeong SH, el al. Orally fast disintegrating tablets: develop- ments, technologies, taste - masking and clinical studies[J]. Crit Rev Ther Drug Carrier Syst, 2004,21 (6) : 433 - 475. 被引量:1
  • 4Shimizu T, Nakano Y, Morimoto S, et al. Formulationstudy for lansoprazole fast - dislntegr - ating tablet . Effect of compression on dissolution behavior [J]. Chem Pharm Bull, 2003, 51 (8) : 942 - 947. 被引量:1
  • 5Abdelbary G, Eouani C, Prinderre P. Deternlination of the in vitro disintegra- tion profile of rapidly disintegrating tablets and correlation with oral disinte- gration [ J ]. Int J Pharm, 2005, 292 ( 1 - 2) : 29 - 41. 被引量:1
  • 6Carlin EJ, Garruto JR. Effervescent systems with simplified packaging requirements: US, 5912012[P]. 1999 - 06 - 15. 被引量:1
  • 7肖春.盐酸氨溴索咀嚼软胶丸及其制备方法:中国.200510020319.1[P].2005-10-12. 被引量:1
  • 8刘保起,李明华,张世伟.一种盐酸氨溴索冻干粉针及其制备方法:中国,200810009183.8[P].2008-07-23. 被引量:1
  • 9王宗贵,耿燕,孙宏张.盐酸氨溴索滴丸及其制备方法:中国,200410064821.8[P].2005-07-06. 被引量:1
  • 10赵敬民,赵良彬.盐酸氨溴索颗粒剂:中国,200410081177.5[P].2005-06-22. 被引量:1

共引文献110

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部